TREM2 and Alzheimer disease: Prominent among these microglial AD-risk genes is the “triggering receptor expressed on myeloid cells 2” (TREM2) (4, 5, 6), of which there are several missense mutations in the ectodomain, including R47H, associated with increased risk for AD (4, 5, 6).